1Department of Pharmaceutical Quality Assurance, PRES College of Pharmacy (Women’s), Chincholi, Nashik-422102
2Department of Pharmaceutical Chemistry, PRES College of Pharmacy (Women’s), Chincholi, Nashik-422102
A mental illness called schizophrenia is characterised by disturbances in cognition, perception, emotional responsiveness, and social relations. Around 24 million individuals, or 1 in 300 persons (0.32%), worldwide suffer from schizophrenia. For men, this incidence is 1 in 222 (0.4%). Here, a person's capacity for thought, emotion, and behaviour is impacted. Memory loss and attention problems could also be present. According to neurological theory, imbalance of certain neurotransmitters, including: Gamma-aminobutyric acid (GABA) expression levels in the prefrontal cortex, an excess of dopamine, decreased glutamate levels in the cerebrospinal fluid, or decreased serotonin levels Schizophrenia is thus the most prevalent mental disease of our time, causing severe disruptions for those who have it and consuming a sizable percentage of the health system's limited resources. In this essay, the most current research on introduction, etiology, symptoms, and remedies is reviewed. Researching this disease ran into some methodological issues, which are addressed. The results of therapies available for this condition have improved, but whether a patient gets these treatments may rely on the services that the local community is willing to provide.
Monali Khatake*, Vinayak Gaware, Rahul Khaire, Charushila Bhangale, Overview and Treatments of Schizophrenia: A Recent Update, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 4, 153-165. https://doi.org/10.5281/zenodo.7847211